Katharine Giles
Venture Partner, Brandon Capital; CEO, OncoRes Medical
All companies 
Brandon Capital
2 conversations across 2 shows.
Meet the people behind the company.
Latest conversation · Investment Thesis
Katharine Giles of Brandon Capital - The Investment Thesis Behind Backing Life SciencesAbout Brandon Capital
Brandon Capital is a Melbourne-based venture capital firm that invests in life sciences companies from seed stage through to expansion. It manages the Brandon BioCatalyst funds, formerly the Medical Research Commercialisation Fund, backed by superannuation funds, CSL, governments and research institutes. Its sixth fund closed at A$439 million in July 2025. Chris Nave is a co-founder.
- Sector
- Venture capital (life sciences)
- Business model
- Venture fund (life sciences)
- Headquarters
- Melbourne
- Offices
- Melbourne, Sydney, London
- Markets
- Australia, New Zealand, US, UK
Sources: brandoncapital.vc, brandoncapital.vc
The people on Day One.
Prashanth Rajan
Associate, Brandon Capital
Hear from the team.
Spot something wrong? Suggest a correctionUpdated 29 October 2026
Be part of
the conversation.
Put your brand alongside the voices founders, investors and operators come to hear.
Explore sponsorshipWant a show like this for your fund or company?
We're W2D1 Media — the team behind the Day One Network, and we helped build Blackbird Ventures' Wild Hearts. We turn podcasts into trust, authority and pipeline.
